Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07661706 · ClinicalTrials.gov registry record

Data Collection of New Spectral CT Imaging Method

A clinical trial, sponsored by GE Healthcare.

Recruiting
Registry status
50
Enrollment target

NCT07661706: Recruiting study, sponsored by GE Healthcare.

NCT07661706 is a clinical trial that is actively recruiting participants, run by GE Healthcare. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07661706 is actively recruiting participants, sponsored by GE Healthcare.

RECRUITING
Registry status
50 participants
Enrollment target

Study Summary

The purpose of the study is to collect data to evaluate utility of a next generation spectral CT system in a clinical setting.

Primary Outcome

Number of participants who research scan is deemed evaluable (i.e., no issues with participant motion or contrast administration/timing)

Interventions

  • DEVICE Research CT

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-12-19
Est. Completion 2026-08
GE Healthcare

99 total trials

What NCT07661706 shows while recruiting

NCT07661706 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Research CT is the first listed.

NCT07661706 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07661706 about?

NCT07661706 is a clinical study titled "Data Collection of New Spectral CT Imaging Method". The purpose of the study is to collect data to evaluate utility of a next generation spectral CT system in a clinical setting.

What is the current status of trial NCT07661706?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-12-19. Estimated completion is 2026-08.

What interventions are being tested in trial NCT07661706?

The interventions under investigation include: Research CT (DEVICE).

Who is sponsoring clinical trial NCT07661706?

This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07661706, the US trial registry maintained by the National Library of Medicine. NCT07661706 (small enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.